Journal article · 2020 · Open access
Monoclonal antibodies: Emergence, present and outlook
Chinese Science Bulletin (Chinese Version), 65(28-29), 3085–3090 · Published 1 January 2020 · DOI 10.1360/tb-2020-0490
In brief
“Monoclonal antibodies: Emergence, present and outlook” is a 2020 journal article by Ji Gao and 3 co-authors, published in Chinese Science Bulletin (Chinese Version). OpenAlex counts 2 citations as of 18 November 2026. It is open access: the full text is free to read at Chinese Science Bulletin (Chinese Version).
- Citations
- 2
- Most cited in
- 2023 (1)
- Field-weighted impact
- 0.08
- References
- 38
- Authors
- 4
Abstract
Monoclonal antibodies are of great use in research and clinic. The first monoclonal antibody production method, hybridoma technology, was marked in the paper “Continuous cultures of fused cells secreting antibody of predefined specificity” by Milstein and Köhler in 1975 in Nature. Based on that paper, we took a retrospective and forward look of this technique. In the early research of antibodies and B cells, the low specificity and bad reproductivity of polyclonal antibodies called for new methods to produce highly specific antibodies. Fortunately, the scientists encountered the key prerequisites of the hybridoma method: (1) Mouse multiple myeloma cell lines, which can secrete antibodies and infinitely reproduce in vitro; (2) SRBC (sheep red blood cell) plates that can screen the cells secreteing anti-SRBC antibodies; (3) proper cell fusion methods like Sendai virus and PEG. Based on all these materials and methods, Milstein and Köhler fused spleen cells of immunized mice with mouse myeloma cell line P3-X67Ag8 by inactivated Sendai virus and screened to clone the fused cells that can secrete anti-SRBC antibodies. They also used HAT medium to ensure that only fused cells from spleen cells and myeloma cells can survive. In this way, they obtained the immortal cells that can produce a single type of antibody with a predefined antigen-specificity, or say, hybridoma cells that can produce monoclonal antibodies. This powerful tool of hybridoma was quickly applied and improved. Milstein and Köhler were awarded the Nobel prize and Lasker award in 1984. Despite the great commercial potential of hybridoma in medication and science research, Milstein and Köhler did not patent the method, making it free to use by anyone in the world. The monoclonal antibodies produced by hybridoma were proved highly versatile in the laboratory. Besides great insights provided to us in basic immunology research, they become the indispensable tool to precisely qualify, quantify, and localize macromolecule in all fields of research. Fluorescence imaging, Western blotting, flow cytometry and microarray methods all make use of monoclonal antibodies. Upon chimera, humanized and human monoclonal antibody development, the application and success of monoclonal antibodies on the biopharma market are even greater. Monoclonal antibody medicines to treat cancer and autoimmune diseases are making billions of dollars every year. Notably, among these medicines, anti-PD-1 and anti-CTLA-4 are awarded Nobel prize in 2018 as anti-tumor immune checkpoint inhibitors. Monoclonal antibody medicines for contagious diseases like Ebola also shows advantages over others. For the new outbreak of COVID-19 around the world, monoclonal antibodies are also promising in offering new cures. Presently, the production of monoclonal antibodies…
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Gao, J., He, J., Wang, Q., & Liu, W. (2020). Monoclonal antibodies: Emergence, present and outlook. Chinese Science Bulletin (Chinese Version), 65(28-29), 3085–3090. https://doi.org/10.1360/tb-2020-0490
MLA 9
Gao, Ji, et al. “Monoclonal antibodies: Emergence, present and outlook.” Chinese Science Bulletin (Chinese Version), vol. 65, no. 28-29, 2020, pp. 3085–3090. https://doi.org/10.1360/tb-2020-0490.
Chicago
Gao, Ji, Juan He, Qingwen Wang, and Wanli Liu. 2020. “Monoclonal antibodies: Emergence, present and outlook.” Chinese Science Bulletin (Chinese Version) 65 (28-29): 3085–3090. https://doi.org/10.1360/tb-2020-0490.
Harvard
Gao, J. et al. (2020) ‘Monoclonal antibodies: Emergence, present and outlook’, Chinese Science Bulletin (Chinese Version), 65(28-29), pp. 3085–3090. doi:10.1360/tb-2020-0490.
IEEE
J. Gao, J. He, Q. Wang, and W. Liu, “Monoclonal antibodies: Emergence, present and outlook,” Chinese Science Bulletin (Chinese Version), vol. 65, no. 28-29, pp. 3085–3090, 2020, doi: 10.1360/tb-2020-0490.
BibTeX
@article{gao2020monoclonal,
title = {{Monoclonal antibodies: Emergence, present and outlook}},
author = {Gao, Ji and He, Juan and Wang, Qingwen and Liu, Wanli},
journal = {Chinese Science Bulletin (Chinese Version)},
year = {2020},
volume = {65},
number = {28-29},
pages = {3085--3090},
doi = {10.1360/tb-2020-0490},
url = {https://doi.org/10.1360/tb-2020-0490}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- hybridoma technology
- HAT selection
- polyclonal antibodies
- chimeric antibodies
- humanized monoclonal antibody
- human monoclonal antibodies
- anti-PD-1
- anti-CTLA-4
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Gao, J., He, J., Wang, Q., & Liu, W. (2020). Monoclonal antibodies: Emergence, present and outlook. Chinese Science Bulletin (Chinese Version), 65(28-29), 3085–3090. https://doi.org/10.1360/tb-2020-0490
How many times has this paper been cited?
2 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Chinese Science Bulletin (Chinese Version): sign in and open the PDF from this page.
Who wrote this paper?
Ji Gao, Juan He, Qingwen Wang, Wanli Liu.
What is the DOI of this paper?
10.1360/tb-2020-0490, permanently at https://doi.org/10.1360/tb-2020-0490. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.